Inozyme Pharma Inc (NASDAQ:INZY) currently has a daily average trading volume of 2.03M but it saw 1491038 shares traded in last market. With a market cap of 256.96M USD, the company’s current market price of $3.98 remained unchanged while comparing to the previous closing price of $3.98. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.24 and as low as $0.72.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Raymond James which initiated the stock as “Outperform” in its note to investors issued on December 12, 2024, recommending a price target of $26 for it. Jefferies issued its recommendations for the stock as it resumed the price target for the stock in the range of between $16 and $17.
Over the week, INZY’s stock price is moving 0.63% up while it is 167.11% when we observe its performance for the past one month. Year-to-date it is 43.68% up and over the past year, the stock is showing a downside performance of -17.43%.
Currently, Inozyme Pharma Inc’s total number of outstanding shares is 64.47M with 1.23% of that held by the insiders while 90.06% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -203.72% and return on equity (ROE) at -141.69%. Stock’s beta reads 2.29. Stock has a price to book (P/B) ratio of 8.07. Its return on asset (ROA) is -78.44% on average.
